Shatavari (Expanded) for Lactation Support

Research suggests that Shatavari (Asparagus racemosus) has meaningful support as a galactagogue, with multiple randomized controlled trials in human subjects reporting increased prolactin levels, greater milk volume, and faster time to breast fullness in postpartum women, alongside corroborating findings from animal studies in rabbits and buffaloes. Studies indicate that the plant's steroidal saponins, particularly Shatavarin IV, are thought to be the primary active compounds responsible for these lactation-supporting effects, a mechanism discussed across several pharmacological reviews. The overall direction of the evidence is broadly supportive, spanning a 1967 early study through a 2025 RCT, systematic reviews, and formulation-specific trials, though at least one review characterizes the broader galactagogue literature, including Shatavari, as yielding mixed results with limitations in study rigor, sample size, and methodological consistency. Reviewers across multiple publications emphasize that while preliminary clinical evidence is encouraging, more large-scale, well-controlled trials are needed before firm conclusions can be drawn about efficacy and safety.